- Barrons.com•2 days ago
Trump administration policies -- like lower taxes, increased infrastructure spending and less regulation on banks -- are likely to lead to more inflation and are already sparking higher interest rates. ...
- PR Newswire•9 days ago
SAN DIEGO, Nov. 28, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (SRNE) ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, announces it has entered into a loan and security agreement with Hercules Capital, Inc. (HTGC) ("Hercules") for a term loan of up to $75.0 million subject to funding in three tranches. The proceeds will be used for general corporate purposes allowing Sorrento the flexibility to consolidate core programs and more rapidly advance product opportunities in various therapeutic areas. A first tranche of $50.0 million was funded upon execution of the loan agreement on November 23, 2016.
- The Wall Street Journal•26 days ago
Nasty Gal Inc., a millennial-focused online fashion retailer, is seeking access to its lenders’ cash to fund its newly launched restructuring.
HTGC : Summary for Hercules Capital, Inc. Common S - Yahoo Finance
Hercules Capital, Inc. (HTGC)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||13.41 x 200|
|Ask||13.54 x 600|
|Day's Range||13.49 - 13.65|
|52 Week Range||9.92 - 14.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||14.61|
|Dividend & Yield||1.24 (9.15%)|
|1y Target Est||N/A|